EMMPRIN expression is associated with metastatic progression in osteosarcoma.
Han-Soo KimHa Jeong KimMi Ra LeeIlkyu HanPublished in: BMC cancer (2021)
Our data suggest that EMMPRIN acts as a mediator of osteosarcoma metastasis by regulating MMP and VEGF production in cancer cells as well as stromal cells. EMMPRIN could serve as a therapeutic target in osteosarcoma.